McKesson's Q3 profit surged 91%, exceeding EPS expectations but falling slightly short on revenue

From Nasdaq: 2025-02-05 17:33:20

McKesson reported mixed financial results for Q3 2025, beating earnings expectations but falling slightly short on revenue. Operating profit surged by 91% compared to the previous year. The company is a key player in healthcare distribution, focusing on the U.S. and Canada markets. In Q3, revenue from the U.S. Pharmaceutical segment grew, while the RxTS segment saw a 14% increase. Despite challenges in the Medical-Surgical Solutions segment, McKesson made strategic moves like acquiring PRISM Vision Holdings and divesting Canadian retail businesses. The company aims to improve cash management and raised its adjusted EPS guidance for fiscal 2025.

Investors should monitor how McKesson navigates competitive pressures and regulatory changes, as competitors like Cardinal Health could impact its market position. The company’s strategic adjustments and focus on key segments will be crucial for maintaining growth momentum in the coming quarters.



Read more at Nasdaq: McKesson Exceeds EPS, Q3 Profit Surges